《港股》恆指半日跌117點 國泰君安國際漲近13% 光控飆29%
美股道指隔晚(25日)跌106點或0.3%。港元匯價觸及弱方兌換保證,香港金管局自2023年以來首次在市場買入94.2億元,港股早市在多間公司公布配股下走軟。恆指低開129點,初段跌233點見24,240點後跌幅收窄,高見24,411點跌63點,半日跌117點或0.5%,報24,357點;國指跌45點或0.5%,報8,814點;恆生科技指數跌不足1點報5,358點。大市半日成交總額1,420.94億元。
穩定幣概念炒作,中國光大控股(00165.HK)升29%。本港券商股亦抽高,勝利證券(08540.HK)炒高1.3倍,英皇資本(00717.HK)及南華金融(00619.HK)升20%及19%,耀才(01428.HK)、國泰君安國際(01788.HK)及立橋證券(08350.HK)升12.5%至14.2%,其中國泰君安國際半日成交172.9億元,該股早前獲證監會批准提供虛擬資產交易服務,中國光大控股成交亦近30億元。
美元下滑,資源股洛鉬(03993.HK)及五礦資源(01208.HK)升5.9%及5.6%,金股靈寶(03330.HK)、山東黃金(01787.HK)及中國黃金國際(02099.HK)升4.3%至5.1%。港元跌至弱方兌換保證,地產股新世界(00017.HK)、長實集團(01113.HK)、新地(00016.HK)、恆地(00012.HK)及領展(00823.HK)跌1.9%至2.6%。
多間公司公布配股後股價下跌,眾安在線(06060.HK)折讓8.5%配股淨籌39億元,股價跌4.7%。信達生物(01801.HK)折讓4.9%配股淨籌42.7億元,股價跌3.9%。順豐(06936.HK)折讓8.8%配股另溢價4.9%發可換股債,共淨籌逾58億元,股價跌4.3%。
醫藥股普遍回吐,Vor Bio與榮昌生物(09995.HK)訂立許可協議,榮昌生物收到1.25億美元首付款,榮昌生物股價跌16.9%。康方(09926.HK)、諾誠健華(09969.HK)及綠葉製藥(02186.HK)跌3.7%至4.7%。
科技股方面,騰訊遊戲雲發布小遊戲全方位解決方案,騰訊(00700.HK)跌0.4%。阿里(09988.HK)及新東方(09901.HK)跌2.3%及2.7%,美團(03690.HK)及網易(09999.HK)跌1.1%及0.5%,中芯(00981.HK)、快手(01024.HK)及嗶哩嗶哩(09626.HK)升1.9%至2.3%,京東(09618.HK)及百度(09888.HK)升不足1%,金蝶(00268.HK)升5.2%。
車股方面,小米(01810.HK)將發布YU7,股價高開後回吐,半日跌0.3%。比亞迪(01211.HK)及吉利(00175.HK)跌2.4%及2.5%。電池股寧德時代(03750.HK)升1.8%。汽車代理中升(00881.HK)升3.3%。消費股方面,李寧(02331.HK)、九毛九(09922.HK)及滔搏(06110.HK)升3.5%至3.8%。濠賭股逆市上漲,新濠國際(00200.HK)炒高12%,澳博(00880.HK)升4.9%,美高梅中國(02282.HK)及永利澳門(01128.HK)升4.2%及3.9%,銀娛(00027.HK)升2.7%。
其他股份方面,匯控(00005.HK)升0.2%,港交所(00388.HK)平收報422元,友邦(01299.HK)跌1.1%。香港中旅(00308.HK)午前股價抽升,半日飆61.7%報1.73元,成交逾7億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.